文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

撤稿声明：丹参酮IIA和顺铂联合通过下调NF-κB/COX-2/VEGF通路抑制食管鳞状细胞癌

Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway.

出版信息

Front Oncol. 2021 Jun 29;11:721658. doi: 10.3389/fonc.2021.721658. eCollection 2021.

DOI:10.3389/fonc.2021.721658

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8277573/

Abstract

[This retracts the article DOI: 10.3389/fonc.2020.01756.].

摘要

[本文撤回文章DOI：10.3389/fonc.2020.01756。]

相似文献

1

Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway.撤稿声明：丹参酮IIA和顺铂联合通过下调NF-κB/COX-2/VEGF通路抑制食管鳞状细胞癌

Front Oncol. 2021 Jun 29;11:721658. doi: 10.3389/fonc.2021.721658. eCollection 2021.

2

Retraction: Corrigendum: Tan IIA Combined With DDP Inhibits Esophageal Squamous Cell Carcinoma Down-Regulating the NF-kB/COX-2/VEGF Pathway.撤回：勘误：丹参酮IIA联合顺铂通过下调NF-κB/COX-2/VEGF通路抑制食管鳞状细胞癌

Front Oncol. 2021 Jun 24;11:721663. doi: 10.3389/fonc.2021.721663. eCollection 2021.

3

Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway.勘误：丹参酮IIA和顺铂联合通过下调NF-κB/COX-2/VEGF通路抑制食管癌

Front Oncol. 2021 Apr 6;11:670798. doi: 10.3389/fonc.2021.670798. eCollection 2021.

4

Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway.丹参酮IIA和顺铂联合通过下调NF-κB/COX-2/VEGF通路抑制食管癌

Front Oncol. 2020 Sep 10;10:1756. doi: 10.3389/fonc.2020.01756. eCollection 2020.

5

Tanshinone IIA combined with cisplatin synergistically inhibits non-small-cell lung cancer in vitro and in vivo via down-regulating the phosphatidylinositol 3-kinase/Akt signalling pathway.丹参酮 IIA 联合顺铂通过下调磷脂酰肌醇 3-激酶/ Akt 信号通路协同抑制非小细胞肺癌的体内外生长。

Phytother Res. 2019 Sep;33(9):2298-2309. doi: 10.1002/ptr.6392. Epub 2019 Jul 3.

6

Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells.丹参酮 IIA 通过 p38 MAPK 诱导凋亡及下调顺铂耐药卵巢癌细胞中的 ERCC1 和肺耐药蛋白。

Oncol Rep. 2011 Mar;25(3):781-8. doi: 10.3892/or.2010.1107. Epub 2010 Dec 13.

7

Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.丹参酮IIA抑制脂多糖诱导的RAW 264.7细胞中NF-κB的激活：NIK-IKK、ERK1/2、p38和JNK信号通路可能参与其中。

Eur J Pharmacol. 2006 Aug 7;542(1-3):1-7. doi: 10.1016/j.ejphar.2006.04.044. Epub 2006 May 6.

8

Retracted: Tanshinone IIA Induces Apoptosis in Human Oral Cancer KB Cells through a Mitochondria-Dependent Pathway.撤回：丹参酮IIA通过线粒体依赖性途径诱导人口腔癌KB细胞凋亡。

Biomed Res Int. 2017;2017:9496485. doi: 10.1155/2017/9496485. Epub 2017 Nov 21.

9

Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.丹参酮IIA联合阿霉素以协同方式抑制非小细胞肺癌A549细胞系的恶性生物学行为。

BMC Cancer. 2016 Nov 18;16(1):899. doi: 10.1186/s12885-016-2921-x.

10

Tanshinone IIA Inhibits VEGF Secretion and HIF-1α Expression in Cultured Human Retinal Pigment Epithelial Cells under Hypoxia.丹参酮IIA抑制缺氧条件下培养的人视网膜色素上皮细胞中VEGF的分泌和HIF-1α的表达。

Curr Eye Res. 2017 Dec;42(12):1667-1673. doi: 10.1080/02713683.2017.1355467. Epub 2017 Sep 22.